Skip to content

Comparison of the brain-protective effects of dexmedetomidine administered via nasal route and intravenous route in elderly patients undergoing laparoscopic surgery

Comparison of the brain-protective effects of dexmedetomidine administered via nasal route and intravenous route in elderly patients undergoing laparoscopic surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127622
Enrollment
Unknown
Registered
2026-07-03
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic surgery

Interventions

Experimental group:After the patient entered the room: 2 sprays of dexmedetomidine were administered into each nostril (totaling 100 µg)
Control group:10 minutes before anesthesia induction: Slowly infuse 1 microgram per kilogram of dexmedetomidine over 10 minutes.

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. At our hospital, patients underwent laparoscopic surgery under general anesthesia and the operation duration was >=2 hours (including but not limited to radical gastrectomy for gastric cancer, radical resection for colorectal cancer); 2. Age is 65 years old or above; 3. NYHA classification: Grade I - II; 4. The American Society of Anesthesiologists (ASA) classification ranges from grade I to grade III; 5. The preoperative Montreal Cognitive Assessment (MoCA) score was >=26 points, and the Mini-Mental State Examination (MMSE) score was >23 points.

Exclusion criteria

Exclusion criteria: 1. Preoperative neurological/psychiatric system diseases: history of old cerebral infarction, cerebral hemorrhage, epilepsy, and Parkinson's disease; 2. Combined severe cardiovascular diseases: old myocardial infarction, unstable angina pectoris, cardiac insufficiency; 3. There are contraindications for the use of dexmedetomidine (such as second-degree or higher atrioventricular block, severe bradycardia); 4. Abnormalities in the nasal cavity anatomy or active nasal diseases; 5. Severe impairment of liver and kidney functions: Child-Pugh classification >=B grade or eGFR <60 mL/min/1.73 m^2.

Design outcomes

Primary

MeasureTime frame
Neuron-specific enolase (NSE) and S100ß in peripheral venous blood;Postoperative cognitive function;Delirium;

Secondary

MeasureTime frame
Baseline Information;Hemodynamic Parameters;Drug Consumption;Input and Output of Fluids(;Adverse Reaction Occurrence;Number of Rescue Analgesic Interventions;

Countries

China

Contacts

Public ContactQingping Wen

The First Affiliated Hospital of Dalian Medical University

wqp.89@163.com+86 411 83635972

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026